Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

DAIICHI S : Notice on Details of the Share Options

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/12/2011 | 10:20am CET
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126

http://www.daiichisankyo.com/Notice on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)

Reference

Date of Board of Directors resolution: June 27, 2011

###
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DAIICHI SANKYO COMPANY, LI
02/20 DAIICHI SANKYO : and ArQule Announce the Completion of the METIV-HCC Phase 3 Stu..
02/16 DAIICHI SANKYO : Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive ..
02/15 DAIICHI SANKYO : to close R&D sites in India and Japan
02/15 DAIICHI SANKYO : Strengthens Authorized Generic Business through Daiichi Sankyo ..
02/13 DAIICHI SANKYO : Announces Further Reorganization of its Research & Development ..
02/06 DAIICHI SANKYO : Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive ..
02/02 DAIICHI SANKYO : Studies from Daiichi Sankyo Have Provided New Information about..
02/02 DAIICHI SANKYO : Announces Continuation of Mobile Healthcare Field Clinic Servic..
01/31 DAIICHI SANKYO : Announces New Chairman and President
01/26 STUDIES CONDUCTED AT DAIICHI SANKYO : physicochemical properties and structural..
More news
Sector news : Pharmaceuticals - NEC
02:48pDJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
01:24pDJBAYER : Proposes Higher Dividend for 2016
11:58a Why TEVA Stock Has Been on a Prolonged Dive
08:48aDJBAYER : Investors Upbeat on Takeover -- WSJ
03:32a Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/17 ArQule's lead product candidate tivantinib flunks late-stage liver cancer stu..
02/03 FDA rejects Charleston and Daiichi's opioid candidate
01/24 Pancreatic Cancer Field Awaits Sparse Data
01/18 Daiichi launches Japan-based study of breast cancer candidate U3-1402
01/10 RHEUMATOID ARTHRITIS : The Big 3 And The Future
Advertisement
Financials ( JPY)
Sales 2017 940 485 M
EBIT 2017 -
Net income 2017 72 254 M
Finance 2017 299 419 M
Yield 2017 2,73%
P/E ratio 2017 23,63
P/E ratio 2018 25,85
EV / Sales 2017 1,61x
EV / Sales 2018 1,68x
Capitalization 1 817 551 M
More Financials
Chart DAIICHI SANKYO COMPANY, LI
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Full-screen chart
Technical analysis trends DAIICHI SANKYO CO...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 2 400  JPY
Spread / Average Target -6,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Joji Nakayama President, CEO & Representative Director
Kentaro Takamura IR Contact, Manager-Finance & Accounting
Glenn J. Gormley Senior Managing Executive Officer, Head-R&D
Masahiko Ohtsuki Executive Officer & Senior Manager-Research
Kazunori Hirokawa Representative Director, VP & GM-Administration
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DAIICHI SANKYO COMPANY..7.15%16 014
JOHNSON & JOHNSON3.17%323 362
ROCHE HOLDING LTD.4.69%209 882
PFIZER INC.3.51%204 018
NOVARTIS AG3.91%200 997
MERCK & CO., INC.11.08%180 289
More Results